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Endometrial stromal nodule (ESN) is the least common of the endometrial stromal tumors. They are rare neoplasms which
are diagnosed in most instances by light microscopy. Although such nodules are benign, hysterectomy has been considered the
treatment of choice to determine the margins of the tumor required for diagnosis and to diﬀerentiate it from invasive stromal
sarcoma Whose prognosis is totally diﬀerent. We report a case of a 45 years old woman, with presurgical diagnosis of adnexal
mass or uterine tumor. She underwent a total abdominal hysterectomy. Pathologic examination revealed an endometrial stromal
nodule. Through this observation, we insist on the fact that the ESNs are rare and benign entities which must be diﬀerentiated
from the other invasive malignant stromal tumors; this can change the ﬁnal prognosis.
1.Introduction
Tumors of endometrial stroma are very rare mesenchymal
tumors of the uterus with cytological and architectural
features reminiscent of endometrial stromal cells [1].
The classiﬁcation of endometrial stromal tumor is dif-
ﬁcult and complicated [2, 3]. The recent World Health
Organization classiﬁcation of tumors of the breast and
female genital organs divides the uterine stromal neoplasms
into three groups: benign endometrial stromal nodule
(ESN), low-grade endometrial stromal sarcoma (LGESS),
and undiﬀerentiated endometrial sarcoma (UES) [4].
ESN is cytologically similar to low-grade stromal sar-
comas, but it is distinguished by its well-circumscribed,
expansile margin, and it is considered clinically benign. In
contrast, UES is a rare but highly malignant sarcoma lacking
overt endometrial stromal diﬀerentiation [1].
In this study, we describe a patient with a stromal nodule
who underwent a total abdominal hysterectomy, and we
insist on the fact that endometrial stromal nodule is a rare
disease to be carefully diﬀerentiated from other stromal
sarcomas, which can change the ﬁnal prognosis.
2.Case
M r sK R ,4 5y e a r so l d ,d i v o r c e d ,G 1 P 1 ,t h y r o i d e c t o m i z e d
under treatment, presented with dull pain and discomfort
in the lower abdomen that had lasted for several weeks. The
patient had her Menarche at the age of 14, and the menstrual
cycles were regular without abnormal uterine bleeding. The
abdominal and pelvic examination revealed the abdominal
pelvic painless mass reaching the umbilicalpoint, some parts
of this mass are soft but the mass dependence on the uterus
was not established; the rest of examination was without
particularity. Abdominal and vaginal ultrasound showed
a 15cm heterogeneous but a well-circumscribed mass,
consisting of cystic and solid parts whose relationship with
the uterusisnot well deﬁned. Novegetationwas noted either
inside or outside of the mass. The ovaries was not visualized
(Figure1).Magneticresonance imaging(MRI)was indicated
to specify the seat of the mass and its relationship with
the neighborhood organs, this MRI has not been done
because of the patient lack of means. The hemoglobin was
paradoxically 8,8g/dl. Laboratory investigations including
serum CA 125, T3, T4, TSH were normal. After being2 Case Reports in Medicine
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Figure 1: Showed a 15cm heterogeneous but well-circumscribed mass, consisting of cystic and solid parts, whose relationship with the
uterus is not well deﬁned; no vegetation was noted either inside or outside of the mass, and the ovaries were not visualized.
transfused for anemia, a laparotomy was done to evaluate
the nature of the mass and extent of the disease. With the
exception of slight uterine enlargement (14cm), operative
ﬁndings were totally normal. The adnexa appeared normal;
the patient underwent abdominal hysterectomy. Because of
the suspicion of leiomyoma perioperatively and the age of
the patient, the tubes and ovaries were preserved.
Gross ﬁnding showed a polypoid and protrude tumor
involving in the myometrium and tend to bulge above
the surrounding myometrium. The tumor has a well-
circumscribed contour, measuring 11 × 10 × 8cmandhas
a ﬂeshy yellow surface (Figure 2). This tumor is intramural
with no connection to the endometrium.
In microscopic ﬁndings, the tumor consists of cells
thatcloselyresemble normal proliferative-phaseendometrial
stromal cells with areas of epithelial-like structures that
have an appearance reminiscent of an ovarian sex cord-
stromal tumor. The tumor cells have uniform, small, darkly
staining round or oval nuclei with granular chromatin
and inconspicuous nucleoli. Mitotic activity is less than
3MF/10HPF.
The epithelial-like cells grow in cords and trabeculae,
they are cuboidal with scanty amphophilic cytoplasm and
nuclei resemble those of the surrounding stromal cells
(Figure 3). The tumor presents expansile, noninﬁltrative
margins that compress the surrounding myometrium.
The tumor was immunoreactive to CD10 (Figure 4)
and hormonal receptors: oestrogen receptor (ER) and pro-
gesterone receptor (PR). Immunostaining for AML (alpha
smooth muscle), desmine, calretinin, cytokeratin AE1/AE3,
and inhibin were negative.
One year after surgery, the woman remains asymp-
tomatic, and is clinically and ultrasonographycally free of
disease.
3.Discussion
Endometrial stromal tumors are among the least common
neoplasms ofthe uterine corpus,with an annual incidenceof
about 2 per million women [1–4].
Benignendometrial stromal noduleis arare subtype that
accounts for about one fourth of the endometrial stromal
tumors which constitute less than 5% of uterine tumors
[5–7].
The diagnosis is in most instances established by light
microscopy. The existence of circumscribed benign neoplas-
tic proliferations of endometrial stromal cells, now known
as “endometrial stromal nodules” has been known for many
years but the literature on these lesions is scanty. Although
large series of endometrial stromal tumors often include
ESN, they are usually few in number [8] and there is only
one large series of cases reported by Tavassoli and Norris
in 1981 about 60 cases of ESN [9] and one probable group
of 11 cases in the older literature [10]. Both those studies
were published before the widespread recognition of the
extent to which endometrial stromal tumors, including ESN,
could be mimicked by highly cellular leiomyomas. They
also antedated the existence of antibodies that facilitate
the distinction between EST and smooth muscle tumors
and help delineate the endometrial stromal and smooth
muscle components in EST with smooth muscle metaplasia.
Recently,Dionigipublishedaseriesof50casesincludingEST
that had an entirely circumscribed margin or had limited
focal inﬁltration at their periphery, and he retained only four
endometrial stromal nodules[11].Also,Amanjit published5
casesofEST/1261endometrialneoplasmsfromJanuary 2001
to December 2004 that correspond to 0,3% of endometrial
neoplasms; one case was diagnosed as endometrial stromal
nodule[12].EndometrialstromalnodulehasbeendeﬁnedasCase Reports in Medicine 3
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Figure 2: The gross inspection of hysterectomy specimen revealed a well-circumscribed yellow tumor measuring 11/10cm that appears
within the myometrial layer that resembled a leiomyoma.
Figure 3: Microscopic ﬁnding: standard coloration (HES).
a well-circumscribed endometrial stromal tumor; however,
focal irregularities or ﬁnger-likeprojections into theadjacent
myometrium are acceptable if none of them exceed 2 to
3mm[8, 9].
Figure 4: Microscopic ﬁnding: immunohistochimycoloration.
ESNs like other uterine neoplasms of stromal origin,
occur primarily in peri- and postmenopausal women. Tavas-
soli and Norris [8, 9] reviewed 60 women with endometrial
stromal nodules; the median age was 47 years. The clinical4 Case Reports in Medicine
presentation is nonspeciﬁc; the patients may present with
vaginal bleeding, enough to produce anemia, pelvic or
abdominal pain or discomfort, or may be asymptomatic
[5, 6, 8, 13]. Our patient had a lower abdominal discomfort,
without menorrhagia but paradoxically the hemoglobin was
8,8g/dl (hiding an anemia) which can be explained as
underestimated anemia or menorrhagia. The most common
preoperative diagnoses were leiomyoma and adnexal masses
[1, 13].
Because the majority of patients are beyond childbearing
years, a hysterectomy is usually required; it permits the
thorough evaluation of the tumor margin too, which is
necessary to distinguish a benign stromal nodule from a
stromal sarcoma [3, 14]. However, in contrast to stromal
sarcomas, patients with stromal nodules have remained
free of disease and no recurrences were noted following
hysterectomy [9, 13].
In a curettage specimen, distinction between ESN and
low-grade ESS is almost impossible, unless the tumor is
very small and the margins can be fully evaluated. In
women of reproductive age who desire to preserve fertility,
diagnostic imaging and hysteroscopy may be used to follow
up tumor growth. In some cases, hormonal therapy with
local excision may be successful. In the series reported by
Tavassoli and Norris, six patients underwent simple excision
of the uterine nodules. One patient had a hysterectomy 4
years later for endometrial hyperplasia, and the pathologic
evaluation revealed no evidence of stromal tumor. The
other ﬁve patients were followed from 6, 2 to 10 years
with no evidence of recurrence [9]. Schilder [13] pub-
lished a successful hormonal therapy (leuprolide acetate)
in decreasing the size of a low-grade endometrial stromal
sarcoma, the patient underwent local excision of the tumor
with preservation of reproductive function. Although the
receptorstatusofstromal noduleshas notbeenstudied,their
similarity on a cellular level to low-grade stromal sarcomas
suggests that a trial of hormonal therapy in this case, when
conservative management was desired, might be successful.
The decrease in tumor size permitted local excision and
preserved reproductive function [13].
Our patient aged 45 years was avid neither for pregnancy
nor for a conservative treatment.
Macroscopically,the tumorischaracteristically a solitary,
well-delineated, round ﬂeshy nodule with a yellow to tan
sectioned surface. The median tumour diameter is 4cm
(range 0.8 to 15cm). It was 11cm in our case. About
two thirds are purely intramural without any apparent
connections to the endometrium. Occasional tumors are
cystic, but foci of necrosis and hemorrhage are rare.
Diﬀerential diagnosis of an endometrial stromal nodule
depends on microscopic ﬁndings.
The histological appearance found endometrial stromal
nodules with areas of epithelial-like structures that resemble
ovarian sex cord tumors. The stromal nodules have expan-
sile, noninﬁltrative margins that compress the surrounding
endometrium and myometrium. Minor irregularities of
the margin are common, but invasion of the surrounding
myometrium indicates that the tumor is a stromal sarcoma,
not a stromal nodule [11, 15].
Endometrial stromal tumors with sex cord-like ele-
ments exhibit a polyphenotypic immunophenotype. There
is most often a mixed epithelial-myoid phenotype, with
immunoreactivity for cytokeratin and actin, and, in some
cases, desmin [16]. Immune-stains for EMA are almost
always negative. In accord with the resemblance to a sex cord
tumor, immunoreactivity for inhibin and CD99 is detected
in epithelial-like structures in about a third of this type of
tumors.
In ourcase, thetumor expresses the CD10and hormonal
receptors. Immunostaining forAML(alpha smooth muscle),
desmine, calretinin, cytokeratin AE1/AE3, and inhibin were
negative.
Endometrial stromal nodule with focal sex cord-like
diﬀerentiationtendtorelapse andmetastase. InClementand
Scully initial report, three of ﬁve patients with followup had
recurrences and two died [16].
4.Conclusion
We present a patient with endometrial stromal nodule.
There is no reliable preoperative diagnostic procedure
to identify this tumour. Clinical presentation is nonspeciﬁc.
Hysterectomy is the treatment of choice.
The diagnosis is done on microscopic examination. The
margins of tumour must be determinate to diﬀerentiate it
from invasive stromal tumors.
Considered as benign tumor, the prognosis is excellent
when the diagnosis is sure.
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